216 related articles for article (PubMed ID: 35204416)
1. Mesonephric-like Adenocarcinoma of the Ovary: Clinicopathological and Molecular Characteristics.
Koh HH; Park E; Kim HS
Diagnostics (Basel); 2022 Jan; 12(2):. PubMed ID: 35204416
[TBL] [Abstract][Full Text] [Related]
2. Mesonephric-Like Adenocarcinoma of Uterine Corpus: A Clinicopathological and Targeted Genomic Profiling Study in a Single Institution.
Ma T; Chai M; Shou H; Ru G; Zhao M
Front Oncol; 2022; 12():911695. PubMed ID: 35865471
[TBL] [Abstract][Full Text] [Related]
3. Mesonephric-like Differentiation of Ovarian Endometrioid and High-grade Serous Carcinomas: Clinicopathological and Molecular Characteristics Distinct from Those of Mesonephric-like Adenocarcinoma.
Choi KH; Kim H; Bae GE; Lee SH; Woo HY; Kim HS
Anticancer Res; 2021 Sep; 41(9):4587-4601. PubMed ID: 34475087
[TBL] [Abstract][Full Text] [Related]
4. Mesonephric-like Adenocarcinoma of the Uterine Corpus: Comprehensive Analyses of Clinicopathological, Molecular, and Prognostic Characteristics With Retrospective Review of 237 Endometrial Carcinoma Cases.
Kim HG; Kim H; Yeo MK; Won KY; Kim YS; Han GH; Kim HS; Na K
Cancer Genomics Proteomics; 2022; 19(4):526-539. PubMed ID: 35732320
[TBL] [Abstract][Full Text] [Related]
5. Mesonephric-like Differentiation of Endometrial Endometrioid Carcinoma: Clinicopathological and Molecular Characteristics Distinct from Those of Uterine Mesonephric-like Adenocarcinoma.
Park S; Bae GE; Kim J; Kim HS
Diagnostics (Basel); 2021 Aug; 11(8):. PubMed ID: 34441384
[TBL] [Abstract][Full Text] [Related]
6. Mesonephric-like Adenocarcinoma of the Uterine Corpus: Comprehensive Immunohistochemical Analyses Using Markers for Mesonephric, Endometrioid and Serous Tumors.
Kim H; Na K; Bae GE; Kim HS
Diagnostics (Basel); 2021 Nov; 11(11):. PubMed ID: 34829389
[TBL] [Abstract][Full Text] [Related]
7. Mesonephric Adenocarcinoma of the Vagina Harboring
Lee H; Kim H; Kim HS
Diagnostics (Basel); 2022 Jan; 12(1):. PubMed ID: 35054285
[TBL] [Abstract][Full Text] [Related]
8. [Adenocarcinomas with mesonephric features in gynecologic tract: a clinicopathological analysis of seven cases].
Liang Y; Ruan HJ; Wang WS; Yu MH; Chen XD; Zhang XF
Zhonghua Bing Li Xue Za Zhi; 2021 Jul; 50(7):791-795. PubMed ID: 34405616
[No Abstract] [Full Text] [Related]
9. Serous Carcinoma of the Endometrium with Mesonephric-Like Differentiation Initially Misdiagnosed as Uterine Mesonephric-Like Adenocarcinoma: A Case Report with Emphasis on the Immunostaining and the Identification of Splice Site
Choi S; Jung YY; Kim HS
Diagnostics (Basel); 2021 Apr; 11(4):. PubMed ID: 33919505
[TBL] [Abstract][Full Text] [Related]
10. Ovarian Mesonephric-Like Adenocarcinoma With Recurrent Liver Metastases: A Case Report with Analysis of Therapeutic Molecular Targets.
Sugitani A; Ogawa A; Yoshida H; Kobayashi-Kato M; Kikkawa N; Tanase Y; Uno M; Ishikawa M; Kato T
Int J Surg Pathol; 2024 May; 32(3):578-585. PubMed ID: 37345348
[TBL] [Abstract][Full Text] [Related]
11. Mesonephric Adenocarcinoma and Mesonephric-like Adenocarcinoma of the Urinary Tract.
Xing D; Liang SX; Gao FF; Epstein JI
Mod Pathol; 2023 Jan; 36(1):100031. PubMed ID: 36788068
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic Characteristics of Mesonephric Adenocarcinomas and Mesonephric-like Adenocarcinomas in the Gynecologic Tract: A Multi-institutional Study.
Pors J; Segura S; Chiu DS; Almadani N; Ren H; Fix DJ; Howitt BE; Kolin D; McCluggage WG; Mirkovic J; Gilks B; Park KJ; Hoang L
Am J Surg Pathol; 2021 Apr; 45(4):498-506. PubMed ID: 33165093
[TBL] [Abstract][Full Text] [Related]
13. Somatic mutation analysis of Mesonephric-Like adenocarcinoma and associated putative precursor Lesions: Insight into pathogenesis and potential molecular treatment targets.
Arslanian E; Singh K; James Sung C; Quddus MR
Gynecol Oncol Rep; 2022 Aug; 42():101049. PubMed ID: 35880223
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Value of Immunostaining for Thyroid Transcription Factor 1 (TTF1) and Paired Box 8 (PAX8) in Distinguishing Pulmonary Metastases of Mesonephric and Mesonephric-like Adenocarcinomas from Primary Lung Adenocarcinomas.
Ji N; Lee Y; Lee SH; Kim HS
Anticancer Res; 2024 May; 44(5):2159-2170. PubMed ID: 38677751
[TBL] [Abstract][Full Text] [Related]
15. Mesonephric-like Adenocarcinoma of the Uterine Corpus: Genomic and Immunohistochemical Profiling with Comprehensive Clinicopathological Analysis of 17 Consecutive Cases from a Single Institution.
Koh HH; Park E; Kim HS
Biomedicines; 2023 Aug; 11(8):. PubMed ID: 37626765
[TBL] [Abstract][Full Text] [Related]
16. Mesonephric-like adenocarcinoma of the ovary with co-existent endometriosis: A case report and review of the literature.
Seay K; Akanbi T; Bustamante B; Chaudhary S; Goldberg GL
Gynecol Oncol Rep; 2020 Nov; 34():100657. PubMed ID: 33088886
[TBL] [Abstract][Full Text] [Related]
17. Ovarian mesonephric-like adenocarcinoma arising in serous borderline tumor: a case report with complex morphological and molecular analysis.
Dundr P; Gregová M; Němejcová K; Bártů M; Hájková N; Hojný J; Stružinská I; Fischerová D
Diagn Pathol; 2020 Jul; 15(1):91. PubMed ID: 32693840
[TBL] [Abstract][Full Text] [Related]
18. Ovarian Combined Low-grade Serous and Mesonephric-like Adenocarcinoma: Further Evidence for A Mullerian Origin of Mesonephric-like Adenocarcinoma.
McCluggage WG; Vosmikova H; Laco J
Int J Gynecol Pathol; 2020 Jan; 39(1):84-92. PubMed ID: 30575604
[TBL] [Abstract][Full Text] [Related]
19. Mesonephric-like adenocarcinoma of the female genital tract: possible role of KRAS-targeted treatment-detailed molecular analysis of a case series and review of the literature for targetable somatic KRAS-mutations.
Brambs CE; Horn LC; Hiller R; Krücken I; Braun C; Christmann C; Monecke A; Höhn AK
J Cancer Res Clin Oncol; 2023 Nov; 149(17):15727-15736. PubMed ID: 37668797
[TBL] [Abstract][Full Text] [Related]
20. [Proliferative lesions with mesonephric features in the gynecologic tract: a clinicopathological analysis of sixteen cases].
Mo N; He CY; Yu HY; Bian XT; Jin YL
Zhonghua Bing Li Xue Za Zhi; 2022 Oct; 51(10):1000-1006. PubMed ID: 36207913
[No Abstract] [Full Text] [Related]
[Next] [New Search]
